Search Results

There are 9267 results for: content related to: Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma

  1. Review of gemcitabine-based combinations for platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue s1, May 2005, Pages: 23–30, J. Sehouli

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1525-1438.2005.15353.x

  2. Preclinical in vivo activity of a combination gemcitabine/liposomal doxorubicin against cisplatin-resistant human ovarian cancer (A2780/CDDP)

    International Journal of Gynecological Cancer

    Volume 16, Issue 1, January 2006, Pages: 222–230, D. GALLO, E. FRUSCELLA, C. FERLINI, P. APOLLONIO, S. MANCUSO and G. SCAMBIA

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1525-1438.2006.00304.x

  3. You have free access to this content
    Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

    Cancer

    Volume 95, Issue 10, 15 November 2002, Pages: 2223–2229, Paula M. Fracasso, Kristie A. Blum, Benjamin R. Tan, Carole L. Fears, Nancy L. Bartlett, Matthew A. Arquette and Romnee S. Clark

    Version of Record online : 31 OCT 2002, DOI: 10.1002/cncr.10937

  4. Systemic anticancer therapy in gynecological cancer patients with renal dysfunction

    International Journal of Gynecological Cancer

    Volume 17, Issue 4, July/August 2007, Pages: 739–763, Y.F. LI, S. FU, W. HU, J.H. LIU, K.W. FINKEL, D.M. GERSHENSON and J.J. KAVANAGH

    Version of Record online : 16 FEB 2007, DOI: 10.1111/j.1525-1438.2007.00847.x

  5. You have free access to this content
    Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 338–347, Wei-Xiang Qi, Feng Lin, Yuan-Jue Sun, Li-Na Tang, Zan Shen and Yang Yao

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12203

  6. Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1002–1013, D. LORUSSO, G. FERRANDINA, E. FRUSCELLA, L. MARINI, V. ADAMO and G. SCAMBIA

    Version of Record online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00331.x

  7. Development of PEGylated Liposomes

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Felix Kratz, Peter Senter, Henning Steinhagen, Pages: 907–949, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch28

  8. You have free access to this content
    Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

    Intervention Review

    The Cochrane Library

    Theresa A Lawrie, Andrew Bryant, Alison Cameron, Emma Gray and Jo Morrison

    Published Online : 9 JUL 2013, DOI: 10.1002/14651858.CD006910.pub2

  9. A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin

    European Journal of Haematology

    Volume 75, Issue 6, December 2005, Pages: 515–517, Chiara Fraulini, Endri Mauro, Gian Matteo Rigolin, Sergio Bissoli, Franca Chierichetti, Stefano Panareo, Luciano Feggi, Luigi Cavazzini and Gianluigi Castoldi

    Version of Record online : 10 NOV 2005, DOI: 10.1111/j.1600-0609.2005.00558.x

  10. Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients

    Australasian Journal of Dermatology

    Volume 56, Issue 4, November 2015, Pages: 294–297, Azura Mohd Affandi, Tatiana Pinto Blumetti, Jillian Wells, Mark Hertzberg and Pablo Fernandez-Peñas

    Version of Record online : 13 DEC 2014, DOI: 10.1111/ajd.12270

  11. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  12. Second-line randomized trials in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue s1, March/April 2008, Pages: 59–66, J.B. VERMORKEN

    Version of Record online : 2 SEP 2008, DOI: 10.1111/j.1525-1438.2007.01161.x

  13. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  14. Ovarian Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt013

  15. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  16. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Version of Record online : 21 OCT 2011, DOI: 10.1002/app.35201

  17. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  18. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  19. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jlcr.1573

  20. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x